We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Automated Device Designed for Blood Group Serology

By LabMedica International staff writers
Posted on 21 Jul 2010
Routine blood typing and other interrelated tests can be performed on a fully automated, high-throughput system. More...
The instrument is adaptable for any immunohematology procedure and easily connected to the host system, with compliant software and intelligent robotics.

The flexible system allows the operator to perform the following tests: blood grouping, reverse grouping, phenotyping, crossmatching, antibody screening, antibody identification, and direct antiglobulin tests.

The IH-1000 system has the capacity to stock reagent supplies of 240 ID-Cards, 28 vials of test cells and diluents as required. The instrument processes without restocking of reagents for an average of six to nine hours, depending on the test profile chosen. The appliance automatically shows the level of the reagent supplies and additional reagents can be introduced at any time. The status of the supplies is checked by the device itself or from a remote location, for example from a Wi-Fi connection.

Bio-Rad Laboratories, Inc., (Hercules, CA, USA) manufactures the IH-1000 which offers integrated quality control and validation, intuitive software, and walk-away convenience for blood banking laboratories. The IH 1000, designed for the blood transfusion laboratory, utilizes the industry accepted gold standard ID-System gel card technology. The instrument has two independent pipetting stations, three centrifuges, and an arm dedicated solely to card transport. There are automated maintenance steps; automatic tube diameter detection and tube decap checks. The machine has a built in integrated back-up system, with pipettors and centrifuges that compensate each other.

John Goetz, Bio-Rad Vice President said, "Our customers who have already worked with the IH 1000 during our testing phase have said the system delivers the highest level of automation as well as improved workflow advantages, without sacrificing the quality of the result."

Related Links:

Bio-Rad Laboratories, Inc



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Automated Urinalysis Solution
UN-9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: New findings demonstrate that anti-Müllerian hormone (AMH) may help identify which breast cancer patients are most likely to benefit from chemotherapy plus endocrine therapy (Image Credit: Shutterstock)

AMH Test Helps Predict Adjuvant Chemotherapy Benefit in Premenopausal Breast Cancer

Hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2-) breast cancer can present a difficult treatment decision in premenopausal patients with low recurrence scores.... Read more

Molecular Diagnostics

view channel
Image Credit: iStock

Sequencing-Based Newborn Screening Identifies Pediatric Cancer Risk at Birth

Newborn screening in the United States relies on heel-stick blood spots to identify rare, treatable disorders through biochemical testing, but these programs generally do not assess inherited cancer risk... Read more

Microbiology

view channel
Image: The QIAstat-Dx BCID GPF Plus AMR Panel is the first QIAstat-Dx panel for bloodstream infections to receive FDA clearance (Photo courtesy of Qiagen)

FDA Clears One-Hour Panel for Bloodstream Infection and AMR Detection

Bloodstream infections can rapidly progress to sepsis, a life-threatening condition affecting an estimated 1.7 million adults in the U.S. each year. Rapid identification of pathogens and antimicrobial... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.